NCT07527221 2026-04-14Safety and Tolerability of ZE74-0282 in Healthy VolunteersEilean TherapeuticsPhase 1 Not yet recruiting40 enrolled
NCT07529951 2026-04-14Study of ZE74-0282 for Patients With JAK2 V617F Positive Blood CancersEilean TherapeuticsPhase 1 Not yet recruiting60 enrolled